Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)
China · Delayed Price · Currency is CNY 11.80
-1.06 (-8.24%)
Sep 3, 2026, 3:00 PM CST
SHA:600721 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,538 | 4,707 | 2,525 | 2,949 | 2,311 | 2,810 | |
Market Cap Growth | 19.88% | 86.43% | -14.37% | 27.58% | -17.75% | 92.55% |
Enterprise Value | 4,273 | 4,438 | 2,278 | 2,794 | 2,228 | 2,775 |
Last Close Price | 11.80 | 12.18 | 6.56 | 7.70 | 6.11 | 7.45 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 151.31 | 115.68 | 60.87 | 227.30 | - | 46.97 |
PS Ratio | 13.21 | 12.12 | 6.55 | 7.99 | 6.61 | 9.99 |
PB Ratio | 5.67 | 5.87 | 3.33 | 4.17 | 3.47 | 4.09 |
P/TBV Ratio | 5.80 | 6.01 | 3.42 | 4.30 | 3.59 | 4.27 |
P/FCF Ratio | 203.92 | 378.87 | 45.34 | 65.76 | 45.52 | 97.96 |
P/OCF Ratio | 134.05 | 154.74 | 31.45 | 47.50 | 43.46 | 80.92 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 12.44 | 11.43 | 5.91 | 7.57 | 6.37 | 9.86 |
EV/EBITDA Ratio | 62.87 | 65.42 | 46.59 | 78.90 | - | 70.83 |
EV/EBIT Ratio | 86.53 | 88.71 | 74.46 | 197.56 | - | 197.68 |
EV/FCF Ratio | 192.03 | 357.24 | 40.91 | 62.31 | 43.89 | 96.75 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | 0 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | - | - | 0.00 | 0.04 | - | 0.16 |
Debt / FCF Ratio | - | - | 0.00 | 0.04 | 0.05 | 0.22 |
Net Debt / Equity Ratio | -0.33 | -0.37 | -0.36 | -0.28 | -0.20 | -0.12 |
Net Debt / EBITDA Ratio | -3.89 | -4.40 | -5.56 | -5.66 | 18.71 | -2.06 |
Net Debt / FCF Ratio | -11.89 | -24.04 | -4.88 | -4.47 | -2.63 | -2.81 |
Asset Turnover | 0.32 | 0.35 | 0.35 | 0.36 | 0.35 | 0.29 |
Inventory Turnover | 3.66 | 3.65 | 2.00 | 1.66 | 1.49 | 0.96 |
Quick Ratio | 2.27 | 2.16 | 1.56 | 1.38 | 1.19 | 1.03 |
Current Ratio | 2.44 | 2.29 | 1.89 | 1.83 | 1.75 | 1.84 |
Return on Equity (ROE) | 3.78% | 5.21% | 5.66% | 1.89% | -5.13% | 9.14% |
Return on Assets (ROA) | 2.83% | 2.83% | 1.76% | 0.86% | -2.06% | 0.90% |
Return on Invested Capital (ROIC) | 9.11% | 9.31% | 6.16% | 2.14% | -5.74% | 2.30% |
Return on Capital Employed (ROCE) | 5.80% | 5.90% | 3.80% | 1.90% | -4.60% | 1.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.66% | 0.86% | 1.64% | 0.44% | -1.50% | 2.13% |
FCF Yield | 0.49% | 0.26% | 2.21% | 1.52% | 2.20% | 1.02% |
Dividend Yield | 0.34% | 0.33% | - | - | - | - |
Payout Ratio | 51.60% | - | - | - | - | 0.07% |
Buyback Yield / Dilution | -0.13% | -0.50% | -0.79% | -0.92% | -0.20% | 3.79% |
Total Shareholder Return | 0.21% | -0.17% | -0.79% | -0.92% | -0.20% | 3.79% |